Претраживање
Приказ резултата 21-30 од 164
Medicinal products used in dermatology: Classification and mechanisms of action / Lekovi za dermatološku primenu - klasifikacija i mehanizmi dejstva
(Savez farmaceutskih udruženja Srbije, Beograd, 2013)
Medicinal products used to treat dermatology diseases can be applied topically or systemically, which offers the possibility of various therapeutic modifications. However, skin changes are numerous and also very common in ...
Liquid extemporaneous pharmaceutical preparations for pediatric patients / Tečni farmaceutski preparati za primenu u pedijatriji izrađeni ex tempore
(Savez farmaceutskih udruženja Srbije, Beograd, 2012)
Many drugs used for the treatment of babies and children are not available in the market in dosage forms appropriate for this population. Moreover, a considerable number of these drugs are not registered for pediatric use. ...
Lipid status in phyisiological non-complicated pregnancy / Lipidni status fiziološke nekomplikovane trudnoće
(Savez farmaceutskih udruženja Srbije, Beograd, 2016)
Specifically altered lipid profile and physiological hyperlipidemia during pregnancy are considered essential for the normal course of pregnancy and fetal development. This specific alteration of the lipid profile raises ...
Development of chromatographic methods for analysis of sulfamethoxazole, trimethoprim, their degradation products and preservatives in syrup / Razvoj hromatografskih metoda za analizu sulfametoksazola, trimetoprima, njihovih degradacionih proizvoda i konzervanasa u sirupu
(Savez farmaceutskih udruženja Srbije, Beograd, 2014)
In this paper the experimental conditions for optimal reversed-phase liquid chromatographic (RP-HPLC) determination of sulfamethoxazole, trimethoprim and preservatives, as well as degradation products of sulfamethoxazole ...
Effects of dermocosmetic/cosmetic products for skin lightening: What is real to expect? / Efekti dermokozmetičkih/kozmetičkih preparata za posvetljivanje kože - šta je realno očekivati?
(Savez farmaceutskih udruženja Srbije, Beograd, 2013)
Hyperpigmentation is the disorder of skin color, hair color, nails and mucous membranes resulting from the increased amount of melanin in these areas, and it is characterized as dark areas, often seeming unacceptable. The ...
Vitamins in cosmetic products: Current opinions and practice / Vitamini u kozmetičkim proizvodima - savremeni stavovi i praksa
(Savez farmaceutskih udruženja Srbije, Beograd, 2017)
Vitamins A, E, C, B3 and provitamin B5 (panthenol), and their numerous derivatives are most widely used in cosmetic products. Cosmetic retinoids (retinol, retinaldehyde, and retinyl esters) have been used for years in ...
Pharmaceutical preparations in prevention and therapy of venous disorders: Pharmaceutical technology aspects / Farmaceutsko-tehnološki aspekti preparata za prevenciju i lečenje poremećaja venske cirkulacije
(Savez farmaceutskih udruženja Srbije, Beograd, 2013)
The main purposes of pharmacotherapy in deep and superficial venous thrombosis are prevention and therapy of acute and chronic venous insufficiency as well as complications such as pulmonary embolism, dermatoses, venous ...
Biopharmaceutical aspects of ciprofloxacin interactions with metallic ions / Biofarmaceutski aspekti interakcije ciprofloksacina i jona metala
(Savez farmaceutskih udruženja Srbije, Beograd, 2011)
The ciprofloxacin - metallic ions interactions are well documented and described in the literature. In vivo studies show that ciprofloxacin bioavailability is reduced in the presence of metallic ions containing preparations. ...
Pharmacoeconomic evaluation of providing pharmacist-managed anticoagulation service to patients on warfarin / Farmakoekonomska evaluacija pružanja farmaceutske usluge pacijentima na antikoagulantnoj terapiji varfarinom
(Savez farmaceutskih udruženja Srbije, Beograd, 2016)
It has been determined that Pharmacist-Managed Anticoagulation Service (PMAS) for patients on warfarin improves anticoagulation control and decreases the rate of bleeding, thus reducing the overall health care costs. This ...
Drugs for rare diseases: An example of modified glucocerebrosidase / Lekovi za retke bolesti - primer modifikovane glukocerebrozidaze
(Savez farmaceutskih udruženja Srbije, Beograd, 2011)
To date, circa 5000 rare diseases have been defined, which in sum affect approximately 6% of total population. The development of drugs for rare diseases is hampered by the limitation of specific knowledge availability and ...